Compare Aptos (APT) vs Immunefi (IMU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Aptos vs Immunefi — how do they compare? Aptos trades at Rp10,727 (market cap Rp9,03T, Rp1,35T 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Aptos is far larger — about 334073.3× Immunefi's market cap, and Aptos's circulating supply is 833M / 2,1B APT (40%) versus 873,4M / 10B IMU (9%) for Immunefi. Which is the better fit depends on your goals — on Pluang, investors hold Aptos for 31 Days and Immunefi for 5 Days on average.
| APT | IMU | |
|---|---|---|
Market Cap | Rp9,03T | Rp27,03M |
Volume (24h) | Rp1,35T | Rp39,91M |
Circulating Supply | 833M / 2,1B APT (40%) | 873,4M / 10B IMU (9%) |
Typical Hold Time | 31 Days | 5 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aptos (APT) trades at Rp10,940 with neutral technical signals across indicators. The token shows mixed momentum with RSI_6 at 83.32 suggesting overbought conditions while ADX_6 at 42.52 indicates strong trend strength. Support levels cluster around Rp10,440-Rp11,027 with resistance at Rp11,614-Rp12,201. Market cap stands at Rp9.11T with 40% of max supply in circulation.
Overall outlook remains neutral with key opportunities in protocol development and ecosystem growth. Major risks include high volatility near resistance levels and regulatory uncertainty. The token's technical positioning suggests cautious trading with clear support/resistance boundaries defining near-term price action.
Immunefi token shows limited market activity with a modest market cap of Rp27,03M and low circulation rate of 9%. The asset demonstrates minimal trading volume and network engagement, with token holders maintaining short 5-day holding periods. Recent coverage appears misaligned with the cryptocurrency's actual blockchain metrics, suggesting potential entity confusion.
Outlook remains cautious due to low liquidity and limited ecosystem development. Key opportunities include potential network growth, while major risks involve low adoption, regulatory uncertainty, and market volatility. Investors should monitor on-chain metrics for signs of genuine protocol activity.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aptos
Aptos is a Layer 1 Proof-of-Stake (PoS) blockchain that utilizes Move, an innovative smart contract programming language based on Rust. It aims to drive mainstream adoption of web3 by enabling a robust ecosystem of decentralized applications (dApps) that address real-word user needs.
Read more on APT →About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →
